Filing Details
- Accession Number:
- 0001209191-14-012016
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-19 19:16:08
- Reporting Period:
- 2014-02-15
- Filing Date:
- 2014-02-19
- Accepted Time:
- 2014-02-19 19:16:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1267487 | L Kathy Hibbs | 301 Penobscot Drive Redwood City CA 94063 | Svp & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-02-15 | 1,022 | $27.62 | 18,679 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2014-02-15 | 838 | $27.62 | 17,841 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2014-02-15 | 742 | $27.62 | 17,099 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2014-02-18 | 1,312 | $27.88 | 15,787 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Footnotes
- Includes 6,170 restricted stock units awarded January 28, 2014, of which 1/3 of the shares vest on each of February 15, 2015, 2016 and 2017.
- Includes 6,700 restricted stock units awarded February 5, 2012, of which 1/3 of the shares vest on each of February 15, 2014 and 2015, and the 1/3 of the shares that vested on February 15, 2013, net of withholding.
- Includes 6,000 restricted stock units awarded July 25, 2013, of which 1/3 of the shares vest on each of February 15, 2014, 2015 and 2016.
- Includes 6,700 restricted stock units awarded February 5, 2012, of which 1/3 vest on February 15, 2015, and the 1/3 of the shares that vested on each of February 15, 2013 and 2014, net of withholding.
- Includes 6,000 restricted stock units awarded July 25, 2013, of which 1/3 of the shares vest on each of February 15, 2015 and 2016, and the 1/3 of the shares that vested on February 15, 2014, net of withholding.
- These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on May 28, 2013.
- Represents weighted average sale price. Actual sale prices ranged from $27.51 to $28.32.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Includes an aggregate of 12,405 shares of common stock issuable pursuant to previously reported restricted stock units awards that have not vested.
Billionaire Hedge Funds
